See the DrugPatentWatch profile for Icatibant
What is an icatibant API?
“ Icatibant API” usually means the active pharmaceutical ingredient (API) used to make medicines containing icatibant, a synthetic bradykinin B2 receptor antagonist. Icatibant is used in certain bradykinin-mediated conditions; products that contain icatibant are commonly associated with hereditary angioedema (HAE) treatment. The API is the drug substance that manufacturers formulate into finished dosage forms.
What is icatibant used for clinically?
Icatibant is used for acute attacks of hereditary angioedema (HAE), where bradykinin plays a central role in causing swelling. By blocking bradykinin B2 receptors, it helps stop attacks.
Is icatibant only available as prescription medicines?
Yes. Icatibant is a prescription medicine in jurisdictions where it is marketed. Any “icatibant API” supply is typically intended for licensed pharmaceutical manufacturing, not for consumer use.
What forms do icatibant-containing products come in?
Commonly, icatibant medicines are supplied as injection products (the finished drug product manufacturer selects the final formulation, dose, and delivery device). The API is manufactured separately and then formulated into that injection.
Why do people search for “icatibant API” (and what they usually mean)
Searches for “icatibant API” are typically tied to one of these needs:
- sourcing the drug substance for contract manufacturing or production
- understanding quality/availability (e.g., supplier documentation)
- confirming whether a supplier offers icatibant as an API rather than a finished product
What should you check when buying or qualifying an API supplier?
If you are sourcing icatibant API for manufacturing, the key items typically include:
- regulatory status and documentation needed for import/production
- evidence of GMP manufacturing and batch traceability
- analytical data (for example, identity, purity/impurities, and stability-related information)
- packaging/labeling and shipping requirements for controlled substances (varies by country)
How can icatibant API information differ from “icatibant injection”?
The API is the pure drug substance; icatibant injection is the finished, regulated product with:
- excipients,
- a specific strength and presentation,
- validated manufacturing controls,
- and regulatory approval for a particular indication and dosing regimen.
Sources
The information above explains what “icatibant API” generally refers to and how icatibant is used clinically, but you did not provide specific product/supplier names, country, or dosage form. If you share your goal (e.g., supplier qualification, regulatory status in a specific country, or clinical use), I can narrow it to the most relevant details.